The FDA just recently cleared the Sequitor Steerable Guidewire, from Biosphere Medical, to be marketed the US. BioSphere Medical Inc. is the innovative medical device company using bioengineered microscopes to treat uterine fibroids, hypervascularized tumors and vascular malformations by a procedure called embolization. Here’s how Sequitor follows up on that:
Designed specifically to address the needs of interventionalists, Sequitor facilitates the placement of catheters within the peripheral vasculature for various interventional procedures, including both uterine fibroid embolization and embolization of hypervascularized tumors, such as liver tumors.
The Sequitor has the following characteristics:
— A durable atraumatic polymer tip that reduces the risk of vascular spasm but retains its shape for selective vessel access;
— A highly visible distal segment, comprised of a radiopaque coil and polymer jacket, which provides visibility under live imaging;
— A specially tempered wire core designed to transmit one-to-one torque response without kinking; and
— PASSTHRU(TM) lubricious, hydrophilic coating that facilitates wire trackability.